Radianskin - combining efficacy and skin tolerance for advanced skin whitening

(PresseBox) ( Monheim, )
Skin whiteners remain one of the fastestgrowing segments in the global cosmetic and personal care market. In Asian countries in particular, the increase in demand shows no signs of slowing down. In addition, the growing number of antiaging products claiming an improvement of skin radiance as well as line extensions towards skin care products for the reduction of age spots and evening of skin tone have contributed to the increased demand for skin whitening actives. However, in addition to whitening efficacy, consumers today are looking for products with superior skin tolerance as an alternative to hydroquinone and kojic acid. Radianskin from Laboratoires Sérobiologiques (LS), Cognis' active ingredient business, helps manufacturers to deliver all these benefits. The new skin lightener thus marks a major step forward in skin whitening.

The skin whitening segment is still one of the most dynamic in the cosmetics and care market. However, this does not mean that success can be taken for granted, or that formulating these products does not pose a unique set of challenges. Consumers of whitening products are looking for great lightening results without cell damage or any other adverse sideeffects. On the other hand, there is growing interest in antiaging skin care products that aim to improve skin radiance, and this trend is broadening the market for whitening ingredients. The combination of all these factors has boosted demand for new whiteners with the right combination of performance attributes.

In response, LS has now launched Radianskin, a new skin whitener that perfectly fulfills all the characteristics required in a "modern" skin lightener. The active ingredient in Radianskin is a pure single molecule, rather than a less well defined extract, and provides a significant and visible lightening effect. Based on a scientific approach, Radianskin employs an alternate mode of action when compared to commonly used tyrosinase inhibitors, which differentiates it from most of the existing products on the market. In addition, Radianskin offers a good photoprotective effect helping to prevent skin against UV induced damages while ensuring high skin tolerance due to its positive safety profile.

Scientifically proven effects Clinical studies performed on Asian volunteers have shown that 1% Radianskin significantly lightens the skin after as little as 28 days of treatment, with a lightening effect comparable to market benchmarks. Other in vitro efficacy studies have also proven the active's photoprotective effect against UVBinduced damage, its good skin penetration, and its superior inhibition of melanogenesis compared to wellknown skin lightening products, without any cytotoxic effects.

Radianskin is compatible with a wide range of other ingredients such as aluminum salts, AHAs, vitamin C, sun filters, and TiO2. This makes formulating and handling products that contain this active straightforward, thus providing significant advantages for formulators and manufacturers. Further benefits include excellent stability, and the fact that it does not affect the color or odor of final formulations. Says Anne-Laurie Rodrigues, LS's Communications Manager: "Radianskin offers a unique combination of efficacy, skin tolerance and ease of use. It is suitable for a wide range of skincare applications, such as skin whitening and antiaging products, including those for sensitive skin. The skin whitening market is already growing rapidly, but we believe that this product can give it further stimulus towards developing innovative line extensions within the men's care and body care categories."

Cosmetic applications

Whitening ranges Lightening care products Antiaging skin care products to improve skin radiance Antiage spot creams and serums Men's care products Whitening body care (hands, armpits, chest and forearms)

About Laboratoires Sérobiologiques

Laboratoires Sérobiologiques is Cognis Care Chemicals' active ingredients business. It specializes in the development, manufacture and marketing of innovative cosmetic concepts and active ingredients.
Für die oben stehenden Pressemitteilungen, das angezeigte Event bzw. das Stellenangebot sowie für das angezeigte Bild- und Tonmaterial ist allein der jeweils angegebene Herausgeber (siehe Firmeninfo bei Klick auf Bild/Meldungstitel oder Firmeninfo rechte Spalte) verantwortlich. Dieser ist in der Regel auch Urheber der Pressetexte sowie der angehängten Bild-, Ton- und Informationsmaterialien.
Die Nutzung von hier veröffentlichten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Bei Veröffentlichung senden Sie bitte ein Belegexemplar an service@pressebox.de.